Pro Medicus Ltd
ASX:PME
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
69.62
144.32
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. [ Read More ]
The intrinsic value of one PME stock under the Base Case scenario is hidden AUD. Compared to the current market price of 141 AUD, Pro Medicus Ltd is hidden .
Valuation Backtest
Pro Medicus Ltd
Run backtest to discover the historical profit from buying and selling PME based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Pro Medicus Ltd
Current Assets | 176m |
Cash & Short-Term Investments | 130.4m |
Receivables | 42.5m |
Other Current Assets | 3.1m |
Non-Current Assets | 38.1m |
PP&E | 1.9m |
Intangibles | 20.7m |
Other Non-Current Assets | 15.5m |
Current Liabilities | 23.5m |
Accounts Payable | 1.2m |
Other Current Liabilities | 22.3m |
Non-Current Liabilities | 31.4m |
Long-Term Debt | 988k |
Other Non-Current Liabilities | 30.4m |
Earnings Waterfall
Pro Medicus Ltd
Revenue
|
146.2m
AUD
|
Cost of Revenue
|
-430k
AUD
|
Gross Profit
|
145.8m
AUD
|
Operating Expenses
|
-45.5m
AUD
|
Operating Income
|
100.3m
AUD
|
Other Expenses
|
-30.6m
AUD
|
Net Income
|
69.7m
AUD
|
Free Cash Flow Analysis
Pro Medicus Ltd
AUD | |
Free Cash Flow | AUD |
Pro Medicus had a banner year with transaction revenue surging over 44%, winning seven new contracts in North America, and a notable $15 million renewal with the University of Florida. It completed eight cloud-based implementations, attended a vibrant trade show, and advanced in AI and other medical specialties. With a remarkable revenue increase and significant cash reserves now exceeding $120 million, Pro Medicus declared its largest dividend to date at $0.17 per share. The year saw a rise in margins and the expectation of growing transaction revenue in the next year, supported by growth from new clients and further potential in ancillary products like Archive and Workflow.
What is Earnings Call?
PME Profitability Score
Profitability Due Diligence
Pro Medicus Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Pro Medicus Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
PME Solvency Score
Solvency Due Diligence
Pro Medicus Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Pro Medicus Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PME is 114.84 AUD with a low forecast of 58.44 AUD and a high forecast of 160.31 AUD.
Shareholder Yield
Current shareholder yield for PME is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
PME Price
Pro Medicus Ltd
Average Annual Return | 25.26% |
Standard Deviation of Annual Returns | 51.74% |
Max Drawdown | -61% |
Market Capitalization | 13.4B AUD |
Shares Outstanding | 104 738 514 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical software for practicing of management, training, installation and professional services, after sale support and service products, Promedicus.net secure email and Integration products. Its Visage 7.0 is a healthcare imaging software that provides radiologists and clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images, Picture Archive and Communication System (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and professional services and support products.
Contact
IPO
Employees
Officers
The intrinsic value of one PME stock under the Base Case scenario is hidden AUD.
Compared to the current market price of 141 AUD, Pro Medicus Ltd is hidden .